DeepMed Research

University Of Pittsburgh

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1787-02-28

Employees: 10K

Market Cap: -

Website: http://www.pitt.edu

Clinical Trials

Cognitive/Cerebrovascular Consequences of HTN Treatment

Not Applicable

Completed

Conditions: Hypertension

First Posted Date: 2005-09-08

Last Posted Date: 2007-12-17

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 50

Registration Number: NCT00151138

Locations: 🇺🇸
Dept of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, United States

Health Interventions for Survivors and Primary Support Persons of Spinal Cord Injury

Phase 2

Completed

Conditions: Spinal Cord Injuries

Interventions: Behavioral: Dual Treatment
Behavioral: Caregiver Only Intervention
Behavioral: Control

First Posted Date: 2005-09-07

Last Posted Date: 2015-12-02

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 380

Registration Number: NCT00148239

Locations: 🇺🇸
University of Pittsburgh (UCSUR), Pittsburgh, Pennsylvania, United States
🇺🇸
University of Miami, Miami, Florida, United States

Novel Strategies for Reducing Heart Disease Risk Disparities

Not Applicable

Active, not recruiting

Conditions: Cardiovascular Diseases

Interventions: Behavioral: Nutrition, Exercise, Stress Management Counseling
Other: usual care

First Posted Date: 2005-09-02

Last Posted Date: 2024-10-09

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 2000

Registration Number: NCT00143923

Locations: 🇺🇸
University of Pittsburgh, Pittsburgh, Pennsylvania, United States

Guidelines for Acute Sinusitis

Not Applicable

Completed

Conditions: Sinusitis

First Posted Date: 2005-08-19

Last Posted Date: 2008-05-20

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 240

Registration Number: NCT00132275

Locations: 🇺🇸
University of Pittsburgh/Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States

Gamma-Amino Butyric Acid (GABA)-A Alpha2/3 Study

Phase 2

Completed

Conditions: Schizophrenia

Interventions: Drug: Placebo
Drug: Merck L-830982

First Posted Date: 2005-08-11

Last Posted Date: 2011-10-17

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 16

Registration Number: NCT00129441

Locations: 🇺🇸
University of Pittsburgh, Pittsburgh, Pennsylvania, United States

Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery

Phase 2

Completed

Conditions: Liver Cancer

First Posted Date: 2005-08-10

Last Posted Date: 2017-04-27

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 25

Registration Number: NCT00128596

Locations: 🇺🇸
UPMC Cancer Centers, Pittsburgh, Pennsylvania, United States

The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study)

Not Applicable

Completed

Conditions: Osteoporosis

Interventions: Drug: risedronate (including placebo)

First Posted Date: 2005-07-11

Last Posted Date: 2015-08-13

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 87

Registration Number: NCT00118508

Locations: 🇺🇸
University of Pittsburgh Medical Center (GCRC), Pittsburgh, Pennsylvania, United States

Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery

Phase 3

Completed

Conditions: Liver Cancer

First Posted Date: 2005-05-04

Last Posted Date: 2016-01-18

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 120

Registration Number: NCT00109954

Locations: 🇺🇸
Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States

Genetic Factors That Influence Chronic Obstructive Pulmonary Disease in Hispanics

Completed

Conditions: Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive

First Posted Date: 2005-03-25

Last Posted Date: 2012-12-17

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 679

Registration Number: NCT00106470

Locations: 🇨🇷
Hospital Nacional de Niños, San José, Costa Rica

Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)

Phase 2

Completed

Conditions: Juvenile Dermatomyositis
Dermatomyositis
Polymyositis
Myositis

Interventions: Drug: Rituximab
Drug: Placebo

First Posted Date: 2005-03-22

Last Posted Date: 2015-03-04

Lead Sponsor: University of Pittsburgh

Target Recruit Count: 200

Registration Number: NCT00106184

Locations: 🇺🇸
Cedars-Sinai Medical Center (Adult Site), Los Angeles, California, United States
🇺🇸
Stanford University (Adult Site), Stanford, California, United States
🇺🇸
Beth Israel Deaconess Medical Center (Adult Site), Boston, Massachusetts, United States

and more 28 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy